Six Flags stock rises after appointing John Reilly as new CEO
Director Eric Sachetta of Sensus Healthcare, Inc. (NASDAQ:SRTS) purchased 7,000 shares of common stock on November 21, 2025, at a price of $3.93, for a total transaction value of $27,510. Following the transaction, Sachetta directly owns 140,113 shares of Sensus Healthcare.The insider purchase comes as the stock has fallen 9% over the past week and 43% year-to-date. According to InvestingPro data, Sensus Healthcare appears undervalued compared to its Fair Value assessment, with analysts maintaining a Strong Buy consensus. The company holds more cash than debt and maintains a healthy current ratio of 7.38. Discover more insights with InvestingPro’s comprehensive research report, available for this and 1,400+ other US equities.
In other recent news, Sensus Healthcare reported its third-quarter 2025 earnings, surpassing revenue expectations despite a decline in unit sales. The company posted a net loss of $0.06 per share, which was better than the anticipated loss of $0.08 per share. Revenue reached $6.9 million, exceeding the forecast of $6.25 million. In corporate developments, Sensus Healthcare appointed Michael Sardano as Chief Commercial Officer, adding to his current role as President. This new position will see Sardano directing the company’s global sales, marketing, and commercial strategies. Additionally, Eric Sachetta has joined the Board of Directors, filling the vacancy left by the late Bill McCall. Sachetta currently serves as Chief Wealth Services Officer at Sachetta, LLC. These appointments mark significant changes in the company’s leadership and strategic direction.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.